Specialized Therapies | HIV and Oncology
btn News
Pipeline
Product Pipeline
Theratechnologies develops and commercializes innovative therapies. We have a Phase 1 clinical trial in oncology using our novel and proprietary SORT1+ Technology™. We also plan to initiate a Phase 3 clinical trial to evaluate tesamorelin as a potential treatment for nonalcoholic steatohepatitis (NASH), a severe liver condition which affects a growing number of people around the world.
btn Pipeline
pipeline Phases
Corporate Presentation
Making a difference through innovation
Theratechnologies makes a difference in the lives of patients through the development and commercialization of products addressing important unmet medical needs.
